Talking Medicines Launches New DrugVoice Application Connecting Message Resonance With Intent-to-Prescribe

GLASGOW, Scotland–(BUSINESS WIRE)– #AdvancedDataScience–Talking Medicines, the advanced data science and AI company for life sciences, today announced a new intent-to-prescribe application within DrugVoice, enabled through partnerships with point-of-care data providers. DrugVoice connects Message Resonance Scoreâ„¢ with near-real-time point-of-care signals to show what resonates with clinicians and how it relates to intent-to-prescribe. Pharma invests billions in communications that inform healthcare professionals a

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.